212 related articles for article (PubMed ID: 37699711)
1. Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation.
Nagar N; Naidu G; Mishra A; Poluri KM
J Pharmacol Exp Ther; 2024 Jan; 388(1):91-109. PubMed ID: 37699711
[TBL] [Abstract][Full Text] [Related]
2. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
4. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
5. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
Siafaka PI; Mutlu G; Okur NÜ
Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
[TBL] [Abstract][Full Text] [Related]
7. siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review.
Sargazi S; Arshad R; Ghamari R; Rahdar A; Bakhshi A; Karkan SF; Ajalli N; Bilal M; Díez-Pascual AM
Cell Biol Int; 2022 Sep; 46(9):1320-1344. PubMed ID: 35830711
[TBL] [Abstract][Full Text] [Related]
8. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
Luo MX; Hua S; Shang QY
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
[TBL] [Abstract][Full Text] [Related]
9. Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis.
Mignani S; Shi X; Rodrigues J; Roy R; Muñoz-Fernández Á; Ceña V; Majoral JP
Bioconjug Chem; 2020 Sep; 31(9):2060-2071. PubMed ID: 32786368
[TBL] [Abstract][Full Text] [Related]
10. Emerging nanotherapeutics for antithrombotic treatment.
Zhao Z; Yang F; Zhang X; Sun J; He Z; Luo C
Biomaterials; 2020 Oct; 255():120200. PubMed ID: 32563945
[TBL] [Abstract][Full Text] [Related]
11. Dig & Delve into Protein Based Nanoformulations.
Shariq M; Parveen S; Shamim A; Ahsan F; Kushwaha P; Mahmood T
Drug Res (Stuttg); 2020 May; 70(5):183-187. PubMed ID: 32176922
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.
Dong X; Chu D; Wang Z
Theranostics; 2017; 7(3):751-763. PubMed ID: 28255364
[TBL] [Abstract][Full Text] [Related]
13. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Nanocarriers based novel and effective drug delivery system.
Khizar S; Alrushaid N; Alam Khan F; Zine N; Jaffrezic-Renault N; Errachid A; Elaissari A
Int J Pharm; 2023 Feb; 632():122570. PubMed ID: 36587775
[TBL] [Abstract][Full Text] [Related]
16. Advances in nanotechnology-based platforms for survivin-targeted drug discovery.
George R; Hehlgans S; Fleischmann M; Rödel C; Fokas E; Rödel F
Expert Opin Drug Discov; 2022 Jul; 17(7):733-754. PubMed ID: 35593177
[TBL] [Abstract][Full Text] [Related]
17. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo.
Yang F; Medik Y; Li L; Tian X; Fu D; Brouwer KLR; Wagner K; Sun B; Sendi H; Mi Y; Wang AZ
Small; 2020 Feb; 16(7):e1906360. PubMed ID: 31972070
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle Based Treatment for Cardiovascular Diseases.
Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
